Company

Drug

Indication


Abbvie Inc. (North Chicago)

Imbruvica

Relapsed/refractory marginal zone lymphoma

Adapt Pharma Inc. (Dublin)

Narcan nasal spray 2-mg

Emergency treatment of known or suspected opioid overdose

Allergan plc (Dublin)

Rhofade 1% cream

Persistent facial erythema associated with rosacea

Allergan plc (Dublin)

Avycaz

Complicated urinary tract infections (cUTI)

Astrazeneca plc (London)

Symbicort inhalation aerosol 80/4.5 mcg

Asthma

Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co. (Indianapolis)

Synjardy, Synjardy XR and Glyxambi

Type 2 diabetes and cardiovascular disease

Egalet Corp. (Wayne, Pa.)

Arymo ER extended-release (ER) tablets C-II

Pain

Genentech (unit of Roche Holding AG; Basel, Switzerland)

Lucentis, injected, 0.5 mg

Myopic choroidal neovascularization

Ironwood Pharmaceuticals Inc. (Cambridge, Mass.) and Allergan plc (Dublin)

Linzess

Chronic idiopathic constipation (CIC)

Roxane Laboratories Inc. (wholly owned U.S. subsidiary of Hikma Pharmaceuticals plc; London)

Sodium oxybate oral solution, 500 mg/mL

Cataplexy, or sudden loss of muscle strength, and excessive daytime sleepiness in patients with narcolepsy

Synergy Pharmaceuticals Inc. (New York)

Trulance

Chronic idiopathic constipation

Teva Pharmaceutical Industries Ltd. (Jerusalem)

Vantrela ER

Severe pain

No Comments